Related references
Note: Only part of the references are listed.Constitutive MAP Kinase Activation in Hematopoietic Stem Cells Induces a Myeloproliferative Disorder
Eva Chung et al.
PLOS ONE (2011)
A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice
Natalya Lyubynska et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
M-CSF elevates c-Fos and phospho-C/EBPα(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification
Graham D. Jack et al.
BLOOD (2009)
Erk1/2 MAP kinases are required for epidermal G2/M progression
Phillip A. Dumesic et al.
JOURNAL OF CELL BIOLOGY (2009)
MAPK signaling pathways in the regulation of hematopoiesis
Christian R. Geest et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
Jennifer O. Lauchle et al.
NATURE (2009)
Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion
Tomoharu Yasuda et al.
IMMUNITY (2008)
Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment
Chia-Lin Hsu et al.
BLOOD (2007)
β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice
Andrew Kim et al.
BLOOD (2007)
The role of Erk1 and Erk2 in multiple stages of T cell development
AM Fischer et al.
IMMUNITY (2005)
Phosphorylation of C/EBP alpha inhibits granulopoiesis
SE Ross et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells
DA Ingram et al.
BLOOD (2003)
Neurofibromas in NF1: Schwann cell origin and role of tumor environment
Y Zhu et al.
SCIENCE (2002)
Nf1 and Gmcsf interact in myeloid leukemogenesis
RA Birnbaum et al.
MOLECULAR CELL (2000)
Share Paper
